DAPAGLIFLOZIN VERSUS A DIPEPTIDYL PEPTIDASE 4 INHIBITOR (DPP4) BOTH ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): IMPACT ON HEALTH, QUALITY OF LIFE AND COSTS IN THE TURKISH CLINICAL SETTING

Files

PIIS1098301515041728.pdf (51.47 KB)

Date

2015

Authors

URI

https://www.valueinhealthjournal.com/article/S1098-3015(15)04172-8/pdf
http://hdl.handle.net/11727/4055

Collections

Sağlık Hizmetleri Meslek Yüksekokulu / Vocational School of Health Services
Wos Açık Erişimli Yayınlar
Wos İndeksli Yayınlar Koleksiyonu